STOCK TITAN

PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

PacBio (NASDAQ: PACB), a top developer of high-quality sequencing solutions, announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The company's management will engage in a fireside chat on Thursday, September 5, at 1:05 p.m. Eastern Time.

The event will be live-streamed on PacBio's investors page at investor.pacificbiosciences.com. For those unable to attend live, a replay will be available for at least 30 days following the event. This presentation offers investors and interested parties an opportunity to gain insights into PacBio's latest developments and future prospects in the sequencing technology sector.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-8.13% News Effect

On the day this news was published, PACB declined 8.13%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

MENLO PARK, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, at 1:05 p.m. Eastern Time.

The event will be live-streamed on the company's investors page at investor.pacificbiosciences.com. A replay will be available for at least 30 days following the event.

About PacBio

PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our HiFi long-read sequencing and our SBB® short-read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.

PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.

Contacts

Investors:
Todd Friedman
ir@pacb.com

Media:
pr@pacb.com


FAQ

When is PacBio (PACB) presenting at the Morgan Stanley Global Healthcare Conference?

PacBio (PACB) is presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, at 1:05 p.m. Eastern Time.

How can I watch PacBio's (PACB) presentation at the Morgan Stanley conference?

You can watch PacBio's (PACB) presentation via live-stream on the company's investors page at investor.pacificbiosciences.com.

Will there be a replay available of PacBio's (PACB) Morgan Stanley conference presentation?

Yes, a replay of PacBio's (PACB) presentation will be available for at least 30 days following the event on their investors page.

What type of presentation will PacBio (PACB) give at the Morgan Stanley Healthcare Conference?

PacBio (PACB) management will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference.
Pacific Biosc

NASDAQ:PACB

PACB Rankings

PACB Latest News

PACB Latest SEC Filings

PACB Stock Data

564.57M
274.44M
9.05%
56.36%
12.36%
Medical Devices
Laboratory Analytical Instruments
Link
United States
MENLO PARK